rs1555729503

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_005499.3(UBA2):​c.816_817delAT​(p.Trp273AlafsTer13) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)

Consequence

UBA2
NM_005499.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 7.37

Publications

1 publications found
Variant links:
Genes affected
UBA2 (HGNC:30661): (ubiquitin like modifier activating enzyme 2) Posttranslational modification of proteins by the addition of the small protein SUMO (see SUMO1; MIM 601912), or sumoylation, regulates protein structure and intracellular localization. SAE1 (MIM 613294) and UBA2 form a heterodimer that functions as a SUMO-activating enzyme for the sumoylation of proteins (Okuma et al., 1999 [PubMed 9920803]).[supplied by OMIM, Mar 2010]
UBA2 Gene-Disease associations (from GenCC):
  • ACCES syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • multiple congenital anomalies/dysmorphic syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-34450307-CTA-C is Pathogenic according to our data. Variant chr19-34450307-CTA-C is described in ClinVar as Pathogenic. ClinVar VariationId is 521193.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005499.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBA2
NM_005499.3
MANE Select
c.816_817delATp.Trp273AlafsTer13
frameshift
Exon 9 of 17NP_005490.1Q9UBT2-1
UBA2
NM_001411139.1
c.528_529delATp.Trp177AlafsTer13
frameshift
Exon 10 of 18NP_001398068.1Q9UBT2-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
UBA2
ENST00000246548.9
TSL:1 MANE Select
c.816_817delATp.Trp273AlafsTer13
frameshift
Exon 9 of 17ENSP00000246548.3Q9UBT2-1
UBA2
ENST00000439527.6
TSL:2
c.528_529delATp.Trp177AlafsTer13
frameshift
Exon 9 of 17ENSP00000437484.1Q9UBT2-2
UBA2
ENST00000590048.6
TSL:3
c.732_733delATp.Trp245AlafsTer13
frameshift
Exon 8 of 8ENSP00000467433.2K7EPL2

Frequencies

GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
ACCES syndrome (1)
1
-
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
7.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555729503; hg19: chr19-34941212; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.